Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification

Kidney International

Volumn 89, Issue 5, 2016, Pages 1027-1036

  Paloian, Neil J ^a   Leaf, Elizabeth M ^b   Giachelli, Cecilia M ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Washington   (United States)

Author keywords

calcium; fibroblast growth factor 23; parathyroid hormone; phosphate; uremia; vascular calcification

Indexed keywords

CALCIUM; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR 23; NITROGEN; OSTEOPONTIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; TRANSGELIN; UREA; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; SPP1 PROTEIN, MOUSE;

ABDOMINAL AORTA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; FEMALE; INFLAMMATORY INFILTRATE; KIDNEY CALCIFICATION; KIDNEY FAILURE; KNOCKOUT MOUSE; MINERAL METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; UREMIA; ANIMAL; AORTIC DISEASES; BLOOD; BONE REMODELING; DBA MOUSE; DEFICIENCY; DIET; DISEASE MODEL; GENETICS; KIDNEY; METABOLISM; NEPHROCALCINOSIS; PATHOLOGY; THORACIC AORTA; VASCULAR CALCIFICATION;

ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; AORTIC DISEASES; BIOMARKERS; BONE REMODELING; DIET; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTORS; KIDNEY; MICE, INBRED DBA; MICE, KNOCKOUT; NEPHROCALCINOSIS; OSTEOPONTIN; PHOSPHATES; VASCULAR CALCIFICATION;

EID: 84964678895     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2015.12.046     Document Type: Article

References (63)

1. L. Shavit, P. Jaeger, and R.J. Unwin What is nephrocalcinosis? Kidney Int 88 2015 35 43
2. J.C. Witteman, F.J. Kok, J.L. van Saase, and H.A. Valkenburg Aortic calcification as a predictor of cardiovascular mortality Lancet 2 1986 1120 1122
3. J.C. Witteman, W.B. Kannel, P.A. Wolf, and et al. Aortic calcified plaques and cardiovascular disease (the Framingham Study) Am J Cardiol 66 1990 1060 1064
4. T. Adragao, A. Pires, C. Lucas, and et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients Nephrol Dial Transplant 19 2004 1480 1488
5. D. Russo, S. Corrao, Y. Battaglia, and et al. Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis Kidney Int 80 2011 112 118
6. A. Natali, S. Vichi, P. Landi, and et al. Coronary atherosclerosis in Type II diabetes: Angiographic findings and clinical outcome Diabetologia 43 2000 632 641
7. R.B. Roijers, N. Debernardi, J.P. Cleutjens, and et al. Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries Am J Pathol 178 2011 2879 2887
8. S.E. New, C. Goettsch, M. Aikawa, and et al. Macrophage-derived matrix vesicles: An alternative novel mechanism for microcalcification in atherosclerotic plaques Circ Res 113 2013 72 77
9. N.A. Hassan, E.T. D'Orsi, C.J. D'Orsi, and W.C. O'Neill The risk for medial arterial calcification in CKD Clin J Am Soc Nephrol 7 2012 275 279
10. S. Lehto, L. Niskanen, M. Suhonen, and et al. Medial artery calcification: A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus Arterioscler Thromb Vasc Biol 16 1996 978 983
11. C.M. McEniery, B.J. McDonnell, A. So, and et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals Hypertension 53 2009 524 531
12. G.M. London, S.J. Marchais, A.P. Guerin, and F. Metivier Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia Curr Opin Nephrol Hypertens 14 2005 525 531
13. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis J Am Coll Cardiol 55 2010 1318 1327
14. P. Haase The development of nephrocalcinosis in the rat following injections of neutral sodium phosphate J Anat 119 1975 19 37
15. E.M. Mackay, and J. Oliver Renal damage following the ingestion of a diet containing an excess of inorganic phosphate J Exp Med 61 1935 319 334
16. D.A. Bushinsky, W.R. Parker, and J.R. Asplin Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats Kidney Int 57 2000 550 560
17. M. Darmon, F. Vincent, L. Camous, and et al. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique Br J Haematol 162 2013 489 497
18. L.S. Chawla, P.W. Eggers, R.A. Star, and P.L. Kimmel Acute kidney injury and chronic kidney disease as interconnected syndromes N Engl J Med 371 2014 58 66
19. G.S. Markowitz, S.H. Nasr, P. Klein, and et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing Hum Pathol 35 2004 675 684
20. K.L. Adeney, D.S. Siscovick, J.H. Ix, and et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD J Am Soc Nephrol 20 2009 381 387
21. M.M. El-Abbadi, A.S. Pai, E.M. Leaf, and et al. Phosphate feeding induces arterial medial calcification in uremic mice: Role of serum phosphorus, fibroblast growth factor-23, and osteopontin Kidney Int 75 2009 1297 1307
22. B. Kestenbaum, J.N. Sampson, K.D. Rudser, and et al. Serum phosphate levels and mortality risk among people with chronic kidney disease J Am Soc Nephrol 16 2005 520 528
23. R. Dhingra, L.M. Sullivan, C.S. Fox, and et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community Arch Intern Med 167 2007 879 885
24. M.S. Calvo, A.J. Moshfegh, and K.L. Tucker Assessing the health impact of phosphorus in the food supply: Issues and considerations Adv Nutr 5 2014 104 113
25. G. Schlieper, R. Westenfeld, V. Brandenburg, and M. Ketteler Inhibitors of calcification in blood and urine Semin Dial 20 2007 113 121
26. A. Oldberg, A. Franzen, and D. Heinegard Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence Proc Natl Acad Sci U S A 83 1986 8819 8823
27. T. Standal, M. Borset, and A. Sundan Role of osteopontin in adhesion, migration, cell survival and bone remodeling Exp Oncol 26 2004 179 184
28. J. Sodek, B. Ganss, and M.D. McKee Osteopontin Crit Rev Oral Biol Med 11 2000 279 303
29. Y. Chen, B.S. Bal, and J.P. Gorski Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone J Biol Chem 267 1992 24871 24878
30. K. Singh, D. Deonarine, V. Shanmugam, and et al. Calcium-binding properties of osteopontin derived from non-osteogenic sources J Biochem 114 1993 702 707
31. M. Mirams, B.G. Robinson, R.S. Mason, and A.E. Nelson Bone as a source of FGF23: Regulation by phosphate? Bone 35 2004 1192 1199
32. A. Martin, S. Liu, V. David, and et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling FASEB J 25 2011 2551 2562
33. X. Yan, H. Yokote, X. Jing, and et al. Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells Genes Cells 10 2005 489 502
34. T. Isakova, P. Wahl, G.S. Vargas, and et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease Kidney Int 79 2011 1370 1378
35. T. Shimada, H. Hasegawa, Y. Yamazaki, and et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis J Bone Miner Res 19 2004 429 435
36. L. Shavit, D. Girfoglio, V. Vijay, and et al. Vascular calcification and bone mineral density in recurrent kidney stone formers Clin J Am Soc Nephrol 10 2015 278 285
37. L. Mo, L. Liaw, A.P. Evan, and et al. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both Am J Physiol Renal Physiol 293 2007 F1935 1943
38. R. Ohri, E. Tung, R. Rajachar, and C.M. Giachelli Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin Calcif Tissue Int 76 2005 307 315
39. M. Hirose, K. Tozawa, A. Okada, and et al. Role of osteopontin in early phase of renal crystal formation: Immunohistochemical and microstructural comparisons with osteopontin knock-out mice Urol Res 40 2012 121 129
40. J.A. Wesson Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules J Am Soc Nephrol 14 2003 139 147
41. K.L. Hudkins, C.M. Giachelli, Y. Cui, and et al. Osteopontin expression in fetal and mature human kidney J Am Soc Nephrol 10 1999 444 457
42. M.Y. Speer, Y.C. Chien, M. Quan, and et al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro Cardiovasc Res 66 2005 324 333
43. T. Wada, M.D. McKee, S. Steitz, and C.M. Giachelli Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin Circ Res 84 1999 166 178
44. M.T. Kaartinen, M. Murshed, G. Karsenty, and M.D. McKee Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice J Histochem Cytochem 55 2007 375 386
45. Y. Matsui, S.R. Rittling, H. Okamoto, and et al. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 2003 1029 1034
46. J.S. Shao, O.L. Sierra, R. Cohen, and et al. Vascular calcification and aortic fibrosis: A bifunctional role for osteopontin in diabetic arteriosclerosis Arterioscler Thromb Vasc Biol 31 2011 1821 1833
47. M.Y. Speer, M.D. McKee, R.E. Guldberg, and et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo J Exp Med 196 2002 1047 1055
48. D. Fliser, B. Kollerits, U. Neyer, and et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study J Am Soc Nephrol 18 2007 2600 2608
49. S. Schwarz, B.K. Trivedi, K. Kalantar-Zadeh, and C.P. Kovesdy Association of disorders in mineral metabolism with progression of chronic kidney disease Clin J Am Soc Nephrol 1 2006 825 831
50. S. Lochy, R. Jacobs, P.M. Honore, and et al. Phosphate induced crystal acute kidney injury - an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: Case report and review of the literature Int J Nephrol Renovasc Dis 6 2013 61 64
51. J. Weiss, and M.L. Thorp Acute phosphate nephropathy: A cause of chronic kidney disease BMJ Case Rep 2011 2011 pii:bcr0420102876
52. P. Evenepoel, K. Daenen, B. Bammens, and et al. Microscopic nephrocalcinosis in chronic kidney disease patients Nephrol Dial Transplant 30 2015 843 848
53. J. Lorenzen, R. Kramer, V. Kliem, and et al. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease Eur J Clin Invest 40 2010 294 300
54. D.V. Barreto, A. Lenglet, S. Liabeuf, and et al. Prognostic implication of plasma osteopontin levels in patients with chronic kidney disease Nephron Clin Pract 117 2011 c363 372
55. H. Yamaguchi, M. Igarashi, A. Hirata, and et al. Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients Endocr J 51 2004 499 504
56. C.M. Giachelli, N. Bae, M. Almeida, and et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques J Clin Invest 92 1993 1686 1696
57. H. Matsuzaki, S. Katsumata, M. Uehara, and et al. High-phosphorus diet induces osteopontin expression of renal tubules in rats J Clin Biochem Nutr 41 2007 179 183
58. K. Schulte, K. Berger, P. Boor, and et al. Origin of parietal podocytes in atubular glomeruli mapped by lineage tracing J Am Soc Nephrol 25 2014 129 141
59. Q. Yuan, Y. Jiang, X. Zhao, and et al. Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice J Bone Miner Res 29 2014 693 704
60. W.N. Addison, D.L. Masica, J.J. Gray, and et al. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage J Bone Miner Res 25 2010 695 705
61. S.G. Massry, J.W. Coburn, D.B. Lee, and et al. Skeletal resistance to parathyroid hormone in renal failure: Studies in 105 human subjects Ann Intern Med 78 1973 357 364
62. L. Liaw, D.E. Birk, C.B. Ballas, and et al. Altered wound healing in mice lacking a functional osteopontin gene (spp1) J Clin Invest 101 1998 1468 1478
63. K.A. Cockell, M.R. L'Abbe, and B. Belonje The concentrations and ratio of dietary calcium and phosphorus influence development of nephrocalcinosis in female rats J Nutr 132 2002 252 256